Global Journal of Cancer Therapy


Editorial

 

Novel Strategies to Improve Rituximab Efficacy in Non-Hodgkin's Lymphomas

 

Non-Hodgkin's lymphomas (NHLs) are the second fastest growing cancer in terms of incidence and deaths in the United States and Europe. NHLs are a heterogeneous cancer group including several haematological neoplasias with different degree of aggressiveness. In spite of the progresses, conventional therapies do not ensure long-term survival [1].

http://www.peertechz.com/Cancer-Therapy/GJCT-1-102.php

Comments

Popular posts from this blog

Case Report: Reynolds Syndrome

Successful treatment of Budd- Chiari Syndrome with Percutaneous transluminal Balloon Angioplasty

Apparent Digestibility and Utilization of Protein and Phosphorus in diets of incorporated with Sprouted Sorghum, Phytase and Protease Enzymes for African Catfi sh (Clarias gariepinus)